APA (7th ed.) Citation

M, H., R, P., NF, T., B, S., S, S., S, N., . . . C, H. (2024). Treatment modalities favoring outcome in well-differentiated neuroendocrine tumors G3. Frontiers in endocrinology, 14, 1285529. https://doi.org/10.3389/fendo.2023.1285529

Chicago Style (17th ed.) Citation

M, Hinterleitner, et al. "Treatment Modalities Favoring Outcome in Well-differentiated Neuroendocrine Tumors G3." Frontiers in Endocrinology 14 (2024): 1285529. https://doi.org/10.3389/fendo.2023.1285529.

MLA (9th ed.) Citation

M, Hinterleitner, et al. "Treatment Modalities Favoring Outcome in Well-differentiated Neuroendocrine Tumors G3." Frontiers in Endocrinology, vol. 14, 2024, p. 1285529, https://doi.org/10.3389/fendo.2023.1285529.